SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CuraGen (CRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (86)2/23/1999 9:13:00 AM
From: Mike McFarland  Read Replies (1) of 478
 
CuraGen Corporation Announces Fourth Quarter And
Year End 1998 Financial Results

A $44 Million Stock Offering and Glaxo Wellcome Collaboration Highlight Year

biz.yahoo.com

For the fourth quarter, the Company reported a
net loss attributable to common stockholders of
$8,250,270, or $0.62 per share,

Seems to me that is quite a bit more than expected,
twenty cents worse in fact based on estimate on Yahoo,
but in the race for SNPs maybe spending more and
spending it fast is actually better. Spindoctoring
...I should probably waited a few more days before
scoring my shares...probably could have saved myself
a buck a share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News